A new report reveals FDA inspectors found a lack of adequate microbial controls at a Novo Nordisk plant in the U.S., which manufactures the active ingredient for Ozempic and Wegovy.
Some anesthesiologists are saying recent ASA guidelines don't go far enough to prevent Ozempic stomach risks during surgery.
A gastroparesis lawsuit filed against the makers of Ozempic and Mounjaro claim the diabetes injections should warn patients and their doctors of the risks of severe stomach problems.
The side effects of Ozempic and Wegovy may be linked to cases of stomach paralysis, due to the drugs' ability to hinder digestion, according to a new report.
New guidance calls for patients to stop taking Ozempic, Wegovy and similar drugs before surgery due to risks of vomiting and suffocation.
Some diabetes drugs, like Ozempic and Wegovy, may be linked to increased thyroid cancer risks, European drug regulators warn.
The FDA is warning that some compounding pharmacies are using unapproved versions of the active ingredients of Ozempic and Wegovy to create substitutes of the diabetes and weight loss drugs…
Hair loss experts are warning consumers not to use Ozempic for weight loss due to the risk of permanent hair loss and pattern baldness.
An NBC News report warns consumers are becoming increasingly concerned about Ozempic and Wegovy hair loss as the drugs gain popularity due to their weight loss effects.
A new study links Invokana, Farxiga and similar diabetes drugs to an increased risk of genital infections.
